Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.

Keenen B, Qi H, Saladi SV, Yeung M, de la Serna IL.

Oncogene. 2010 Jan 7;29(1):81-92. doi: 10.1038/onc.2009.304. Epub 2009 Sep 28.

2.

The SWI/SNF complex and cancer.

Reisman D, Glaros S, Thompson EA.

Oncogene. 2009 Apr 9;28(14):1653-68. doi: 10.1038/onc.2009.4. Epub 2009 Feb 23. Review.

PMID:
19234488
3.

Epigenetic regulation in human melanoma: past and future.

Sarkar D, Leung EY, Baguley BC, Finlay GJ, Askarian-Amiri ME.

Epigenetics. 2015;10(2):103-21. doi: 10.1080/15592294.2014.1003746. Review.

4.

MITF in melanoma: mechanisms behind its expression and activity.

Hartman ML, Czyz M.

Cell Mol Life Sci. 2015 Apr;72(7):1249-60. doi: 10.1007/s00018-014-1791-0. Epub 2014 Nov 30. Review.

5.

Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.

Wellbrock C, Arozarena I.

Pigment Cell Melanoma Res. 2015 Jul;28(4):390-406. doi: 10.1111/pcmr.12370. Epub 2015 Apr 17. Review.

6.

Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation.

Marquez SB, Thompson KW, Lu L, Reisman D.

Front Oncol. 2015 Feb 27;4:372. doi: 10.3389/fonc.2014.00372. eCollection 2014. Review.

7.

The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology.

Kawakami A, Fisher DE.

Lab Invest. 2017 Jun;97(6):649-656. doi: 10.1038/labinvest.2017.9. Epub 2017 Mar 6. Review.

PMID:
28263292
8.

SWI/SNF-directed stem cell lineage specification: dynamic composition regulates specific stages of skeletal myogenesis.

Toto PC, Puri PL, Albini S.

Cell Mol Life Sci. 2016 Oct;73(20):3887-96. doi: 10.1007/s00018-016-2273-3. Epub 2016 May 20. Review.

9.

Pro-survival role of MITF in melanoma.

Hartman ML, Czyz M.

J Invest Dermatol. 2015 Feb;135(2):352-358. doi: 10.1038/jid.2014.319. Epub 2014 Aug 21. Review.

10.

Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression.

Ruijtenberg S, van den Heuvel S.

Cell Cycle. 2016;15(2):196-212. doi: 10.1080/15384101.2015.1120925. Review.

11.

MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a "Genetic Switch" Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma.

Eccles MR, He S, Ahn A, Slobbe LJ, Jeffs AR, Yoon HS, Baguley BC.

Front Oncol. 2013 Sep 11;3:229. doi: 10.3389/fonc.2013.00229. Review.

12.

BAF60 A, B, and Cs of muscle determination and renewal.

Puri PL, Mercola M.

Genes Dev. 2012 Dec 15;26(24):2673-83. doi: 10.1101/gad.207415.112. Epub 2012 Dec 7. Review.

13.

The discovery of the microphthalmia locus and its gene, Mitf.

Arnheiter H.

Pigment Cell Melanoma Res. 2010 Dec;23(6):729-35. doi: 10.1111/j.1755-148X.2010.00759.x. Epub 2010 Sep 2. Review.

14.

Mammalian SWI/SNF Enzymes and the Epigenetics of Tumor Cell Metabolic Reprogramming.

Nickerson JA, Wu Q, Imbalzano AN.

Front Oncol. 2017 Apr 4;7:49. doi: 10.3389/fonc.2017.00049. eCollection 2017. Review.

15.

Beyond MITF: Multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanoma.

Seberg HE, Van Otterloo E, Cornell RA.

Pigment Cell Melanoma Res. 2017 Sep;30(5):454-466. doi: 10.1111/pcmr.12611. Review.

PMID:
28649789
16.

A Small Molecule Inhibitor of the MITF Molecular Pathway.

Faloon PW, Bennion M, Weiner WS, Smith RA, Wurst J, Weiwer M, Hartland C, Mosher CM, Johnston S, Porubsky P, Neuenswander B, Dandapani S, Munoz B, Schoenen FJ, Metkar S, Haq R, Fisher DE, Aubé J, Palmer M, Schreiber SL.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2012 Dec 13 [updated 2014 Sep 18].

17.

Pathways from senescence to melanoma: focus on MITF sumoylation.

Leclerc J, Ballotti R, Bertolotto C.

Oncogene. 2017 Aug 21. doi: 10.1038/onc.2017.292. [Epub ahead of print] Review.

PMID:
28825724
18.

Gene-expression profiling in human cutaneous melanoma.

Carr KM, Bittner M, Trent JM.

Oncogene. 2003 May 19;22(20):3076-80. Review.

PMID:
12789283
19.

Transcription factors involved in development and progression of malignant melanoma.

Poser I, Bosserhoff AK.

Histol Histopathol. 2004 Jan;19(1):173-88. doi: 10.14670/HH-19.173. Review.

PMID:
14702186
20.

The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma.

Ahn A, Chatterjee A, Eccles MR.

Mol Cancer Ther. 2017 Jun;16(6):1002-1009. doi: 10.1158/1535-7163.MCT-16-0535. Review.

PMID:
28576947

Supplemental Content

Support Center